Ampio Pharmaceuticals, Inc. Gains 18.75%

Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) rocketted at $1.71, representing a gain of 18.8%. On Tue, Sep 14, 2021, AMPE:NYSEMKT hit a New 2-Week Low of $1.44. The stock appeared on our News Catalysts scanner on Wed, Sep 15, 2021 at 11:22 AM in the 'BIOTECH' category. From Tue, Aug 31, 2021, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Tue, Apr 27, 2021 at $2.01 with a volume of 5M+.
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- GreenSky, Inc. (GSKY:NASDAQ), 53.15%
- INDP (INDP:NASDAQ), 52.05%
- Blue Apron Holdings, Inc. (APRN:NYSE), 44.59%
- IRNT (IRNT:NYSE), 37.78%
- Sphere 3D Corp. (ANY:NASDAQ), 26.07%
- UROY (UROY:NASDAQ), 25.35%
- Marine Products Corporation (MPX:NYSE), 20.78%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 18.75%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 18.58%
- Till Capital Ltd. (TIL:NASDAQ), 16.55%